Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1998-7-7
pubmed:abstractText
We are presently investigating the therapeutic potential of herpes simplex-thymidine kinase-expressing donor T cells in the setting of a T cell-depleted allogeneic bone marrow transplantation. The generation, expansion, and selection of the gene-modified T cells require a 12-day ex vivo culture period in high-dose interleukin (IL)-2 that could significantly alter their in vivo alloreactivity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1365-70
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9625020-Acute Disease, pubmed-meshheading:9625020-Animals, pubmed-meshheading:9625020-Bone Marrow Transplantation, pubmed-meshheading:9625020-Cell Transplantation, pubmed-meshheading:9625020-Gene Transfer Techniques, pubmed-meshheading:9625020-Graft vs Host Disease, pubmed-meshheading:9625020-Herpes Simplex, pubmed-meshheading:9625020-Interleukin-2, pubmed-meshheading:9625020-Lymphocyte Depletion, pubmed-meshheading:9625020-Male, pubmed-meshheading:9625020-Mice, pubmed-meshheading:9625020-Mice, Inbred BALB C, pubmed-meshheading:9625020-Mice, Inbred C57BL, pubmed-meshheading:9625020-T-Lymphocytes, pubmed-meshheading:9625020-Thymidine Kinase, pubmed-meshheading:9625020-Time Factors, pubmed-meshheading:9625020-Tissue Donors, pubmed-meshheading:9625020-Transplantation, Homologous
pubmed:year
1998
pubmed:articleTitle
In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes.
pubmed:affiliation
Laboratoire de Thérapeutique Immuno-moléculaire, Etablissement de Transfusion Sanguine de Franche-Comté, Besançon, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't